JP2018500287A5 - - Google Patents

Download PDF

Info

Publication number
JP2018500287A5
JP2018500287A5 JP2017523358A JP2017523358A JP2018500287A5 JP 2018500287 A5 JP2018500287 A5 JP 2018500287A5 JP 2017523358 A JP2017523358 A JP 2017523358A JP 2017523358 A JP2017523358 A JP 2017523358A JP 2018500287 A5 JP2018500287 A5 JP 2018500287A5
Authority
JP
Japan
Prior art keywords
disease
disorder
compound
pharmaceutically acceptable
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017523358A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018500287A (ja
JP6998204B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/058193 external-priority patent/WO2016069974A1/en
Publication of JP2018500287A publication Critical patent/JP2018500287A/ja
Publication of JP2018500287A5 publication Critical patent/JP2018500287A5/ja
Application granted granted Critical
Publication of JP6998204B2 publication Critical patent/JP6998204B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017523358A 2014-10-30 2015-10-30 Rorγtのモジュレーターとしてのトリフルオロメチルアルコール Expired - Fee Related JP6998204B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462072563P 2014-10-30 2014-10-30
US62/072,563 2014-10-30
PCT/US2015/058193 WO2016069974A1 (en) 2014-10-30 2015-10-30 TRIFLUOROMETHYL ALCOHOLS AS MODULATORS OF RORyt

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2018200608A Division JP6623270B2 (ja) 2014-10-30 2018-10-25 Rorγtのモジュレーターとしてのトリフルオロメチルアルコール
JP2020104927A Division JP2020180129A (ja) 2014-10-30 2020-06-18 Rorγtのモジュレーターとしてのトリフルオロメチルアルコール

Publications (3)

Publication Number Publication Date
JP2018500287A JP2018500287A (ja) 2018-01-11
JP2018500287A5 true JP2018500287A5 (https=) 2018-12-06
JP6998204B2 JP6998204B2 (ja) 2022-02-04

Family

ID=54754732

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2017523358A Expired - Fee Related JP6998204B2 (ja) 2014-10-30 2015-10-30 Rorγtのモジュレーターとしてのトリフルオロメチルアルコール
JP2018200608A Expired - Fee Related JP6623270B2 (ja) 2014-10-30 2018-10-25 Rorγtのモジュレーターとしてのトリフルオロメチルアルコール
JP2020104927A Withdrawn JP2020180129A (ja) 2014-10-30 2020-06-18 Rorγtのモジュレーターとしてのトリフルオロメチルアルコール

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2018200608A Expired - Fee Related JP6623270B2 (ja) 2014-10-30 2018-10-25 Rorγtのモジュレーターとしてのトリフルオロメチルアルコール
JP2020104927A Withdrawn JP2020180129A (ja) 2014-10-30 2020-06-18 Rorγtのモジュレーターとしてのトリフルオロメチルアルコール

Country Status (40)

Country Link
US (2) US9850236B2 (https=)
EP (2) EP3212643B1 (https=)
JP (3) JP6998204B2 (https=)
KR (2) KR20170078750A (https=)
CN (3) CN107108599A (https=)
AR (2) AR102480A1 (https=)
AU (2) AU2015339087B2 (https=)
BR (2) BR112017008816A2 (https=)
CA (1) CA2965512C (https=)
CL (3) CL2017001042A1 (https=)
CO (1) CO2017005014A2 (https=)
CR (2) CR20170166A (https=)
CY (1) CY1121716T1 (https=)
DK (1) DK3212643T3 (https=)
EA (2) EA033699B1 (https=)
EC (1) ECSP17033054A (https=)
ES (2) ES2858503T3 (https=)
GT (1) GT201700090A (https=)
HR (1) HRP20190900T1 (https=)
HU (1) HUE043624T2 (https=)
IL (2) IL251865A0 (https=)
JO (2) JO3571B1 (https=)
LT (1) LT3212643T (https=)
MA (1) MA40873B1 (https=)
ME (1) ME03426B (https=)
MX (2) MX369567B (https=)
PE (2) PE20180250A1 (https=)
PH (2) PH12017500800B1 (https=)
PL (1) PL3212643T3 (https=)
PT (1) PT3212643T (https=)
RS (1) RS58613B1 (https=)
SG (2) SG11201703323PA (https=)
SI (1) SI3212643T1 (https=)
SM (1) SMT201900290T1 (https=)
SV (1) SV2017005429A (https=)
TR (1) TR201907763T4 (https=)
TW (2) TWI667230B (https=)
UY (2) UY36377A (https=)
WO (1) WO2016069974A1 (https=)
ZA (3) ZA201703679B (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201803869A (zh) * 2016-04-27 2018-02-01 健生藥品公司 作為RORγT調節劑之6-胺基吡啶-3-基噻唑
JP2021517563A (ja) * 2018-03-12 2021-07-26 エスカリア バイオサイエンシーズ,ビーブイ 二環式RORγモジュレーター
KR20210060367A (ko) 2018-03-12 2021-05-26 에스칼리에 바이오사이언시스, 비브이 스피로사이클릭 ror-감마 조절제
ES2925473T3 (es) 2018-06-18 2022-10-18 Janssen Pharmaceutica Nv Pirazoles de piridinilo como moduladores de RORyt
CA3103770A1 (en) * 2018-06-18 2019-12-26 Janssen Pharmaceutica Nv Phenyl and pyridinyl substituted imidazoles as modulators of roryt
EP3806958B1 (en) 2018-06-18 2022-09-07 Janssen Pharmaceutica NV 6-aminopyridin-3-yl pyrazoles as modulators of roryt
JP2021528405A (ja) 2018-06-18 2021-10-21 ヤンセン ファーマシューティカ エヌ.ベー. RORγtのモジュレータとしてのアミド置換チアゾール
WO2023232870A1 (en) 2022-05-31 2023-12-07 Immunic Ag Rorg/rorgt modulators for the treatment of virus infections like covid-19
WO2024089216A1 (en) 2022-10-27 2024-05-02 Syngenta Crop Protection Ag Novel sulfur-containing heteroaryl carboxamide compounds
CN119528866B (zh) * 2024-11-28 2025-10-17 河南农业大学 一种含双三氟甲基的香豆素叔醇类化合物及其制备方法和应用

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL91418A (en) 1988-09-01 1997-11-20 Rhone Poulenc Agrochimie (hetero) cyclic amide derivatives, process for their preparation and fungicidal compositions containing them
EP0772606A1 (en) 1994-07-27 1997-05-14 G.D. SEARLE & CO. Substituted thiazoles for the treatment of inflammation
WO2002083111A2 (en) 2001-04-16 2002-10-24 Tanabe Seiyaku Co., Ltd. Imidazole, thiazole and oxazole derivatives and their use for the manufacture of a medicament for the treatment and/or prevention of pollakiuria or urinary incontinence
IL160327A0 (en) 2001-08-13 2004-07-25 Janssen Pharmaceutica Nv 2,4,5-trisubstituted thiazolyl derivatives and their antiinflammatory activity
TWI336697B (en) * 2003-09-19 2011-02-01 Solvay Pharm Bv Thiazole derivatives as cannabinoid receptor modulators
WO2006124687A1 (en) 2005-05-12 2006-11-23 University Of Medicine And Dentistry Of New Jersey Opioid receptor subtype-selective agents
GB0518237D0 (en) * 2005-09-07 2005-10-19 Angeletti P Ist Richerche Bio Therapeutic compounds
CA2639910A1 (en) 2006-01-25 2007-08-02 Synta Pharmaceuticals Corp. Thiazole and thiadiazole compounds for inflammation and immune-related uses
WO2008064318A2 (en) 2006-11-22 2008-05-29 University Of Medicine And Dentistry Of New Jersey Peripheral opioid receptor active compounds
WO2008064317A1 (en) 2006-11-22 2008-05-29 University Of Medicine And Dentistry Of New Jersey Lipophilic opioid receptor active compounds
US20090069288A1 (en) 2007-07-16 2009-03-12 Breinlinger Eric C Novel therapeutic compounds
EP2586311B1 (de) 2008-07-17 2016-12-14 Bayer CropScience AG Heterocyclische Verbindungen als Schädlingsbekämpfungsmittel
TW201040181A (en) * 2009-04-08 2010-11-16 Idenix Pharmaceuticals Inc Macrocyclic serine protease inhibitors
AR079022A1 (es) 2009-11-02 2011-12-21 Sanofi Aventis Derivados de acido carboxilico ciclico sustituidos con acilamino, su uso como productos farmaceuticos, composicion farmaceutica y metodo de preparacion
EP2368886A1 (en) * 2010-03-01 2011-09-28 Phenex Pharmaceuticals AG Novel compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (ROR gamma, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune desease
ES2703176T3 (es) 2010-03-11 2019-03-07 Univ New York Compuestos amido como moduladores de RORgammat y usos de los mismos
US9101600B2 (en) 2010-03-11 2015-08-11 New York University Compounds as RORγt modulators and uses thereof
WO2011115892A1 (en) 2010-03-15 2011-09-22 Griffin Patrick R Modulators of the retinoic acid receptor-related orphan receptors
WO2012027965A1 (en) 2010-09-01 2012-03-08 Glaxo Group Limited Novel compounds
US9505798B2 (en) 2010-11-29 2016-11-29 New York University Steroid compounds as RORyt modulators and uses thereof
JP5981350B2 (ja) 2010-12-28 2016-08-31 ライオン株式会社 口腔状態の判定方法、並びにそのために用いられる分析用具、装置、及びプログラム
US9012651B2 (en) 2011-03-24 2015-04-21 Abbvie Inc. TRPV3 modulators
WO2012158784A2 (en) 2011-05-16 2012-11-22 Theodore Mark Kamenecka Modulators of the nuclear hormone receptor ror
EP2738170B1 (en) 2011-07-29 2017-08-30 Takeda Pharmaceutical Company Limited Heterocyclic compound
BR112014005268A2 (pt) 2011-09-09 2017-03-28 Univ New York compostos de amido como moduladores de ror t e usos dos mesmos
GB201116641D0 (en) * 2011-09-27 2011-11-09 Glaxo Group Ltd Novel compounds
WO2013079223A1 (en) 2011-12-02 2013-06-06 Phenex Pharmaceuticals Ag Pyrrolo carboxamides as modulators of orphan nuclear receptor rar-related orphan receptor-gamma (rorϒ, nr1f3) activity and for the treatment of chronic inflammatory and autoimmune diseases
US20130190356A1 (en) 2011-12-22 2013-07-25 Genentech, Inc. Benzyl sulfonamide derivatives as rorc modulators
CN107007597A (zh) * 2012-05-31 2017-08-04 菲尼克斯药品股份公司 作为孤儿核受体RORγ调节物的经甲酰胺或磺酰胺取代的噻唑及相关衍生物的制药用途
JO3215B1 (ar) 2012-08-09 2018-03-08 Phenex Pharmaceuticals Ag حلقات غير متجانسة بها 5 ذرات تحتوي على النيتروجين بها استبدال بكربوكساميد أو سلفوناميد كمعدلات لمستقبل نووي غير محمي RORy
CA2888485C (en) * 2012-10-16 2021-01-26 Janssen Pharmaceutica Nv Phenyl linked quinolinyl modulators of ror.gamma.t
WO2014093191A1 (en) * 2012-12-12 2014-06-19 Merck Sharp & Dohme Corp. AMINO-PYRIMIDINE-CONTAINING SPLEEN TYROSINE KINASE (Syk) INHIBITORS
JP6368776B2 (ja) 2013-06-04 2018-08-01 アクチュラム・ライフ・サイエンス・アクチエボラーグ トリアゾール化合物およびガンマセクレターゼモジュレーターとしてのその使用
CN103333168B (zh) * 2013-07-23 2015-08-05 清华大学 一种酰胺类化合物及其制备方法与应用
JP6407285B2 (ja) 2013-09-09 2018-10-17 ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company RORγ調節因子
US20150072890A1 (en) 2013-09-11 2015-03-12 20/20 Gene Systems, Inc. Methods and compositions for aiding in the detection of lung cancer
JP6397488B2 (ja) 2013-09-20 2018-09-26 ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company RORγ調節因子
KR20160068948A (ko) * 2013-10-15 2016-06-15 얀센 파마슈티카 엔.브이. RORyt의 이차 알코올 퀴놀리닐 조절제
BR112016008215A2 (pt) * 2013-10-15 2017-09-26 Janssen Pharmaceutica Nv moduladores de quinolinila ligados por alquila de roryt
UA117941C2 (uk) 2013-12-05 2018-10-25 Лід Фарма Холдінг Б.В. МОДУЛЯТОРИ ROR-ГAMMA (RORγ)
WO2015103508A1 (en) 2014-01-06 2015-07-09 Bristol-Myers Squibb Company CARBOCYCLIC SULFONE RORγ MODULATORS
CN106061947B (zh) 2014-01-06 2019-12-03 百时美施贵宝公司 环己基砜RORγ调节剂
WO2015103510A1 (en) 2014-01-06 2015-07-09 Bristol-Myers Squibb Company Heterocyclic sulfone as ror-gamma modulators
WO2015103509A1 (en) 2014-01-06 2015-07-09 Bristol-Myers Squibb Company Pyrrolidinyl sulfone derivatives and their use as ror gamma modulators
WO2015145371A1 (en) 2014-03-27 2015-10-01 Piramal Enterprises Limited Ror-gamma modulators and uses thereof
WO2016069978A1 (en) 2014-10-30 2016-05-06 Janssen Pharmaceutica Nv AMIDE SUBSTITUTED THIAZOLES AS MODULATORS OF RORγT
EP3212641B1 (en) 2014-10-30 2018-12-05 Janssen Pharmaceutica NV Thiazoles as modulators of roryt

Similar Documents

Publication Publication Date Title
JP2018500287A5 (https=)
JP2019515924A5 (https=)
JP2018529650A5 (https=)
HRP20190900T1 (hr) Trifluorometil alkoholi kao modulatori ror-gama-t
JP2015517495A5 (https=)
JP2014503525A5 (https=)
JP2009524691A5 (https=)
JP2012502111A5 (https=)
JP2016529306A5 (https=)
JP2013523802A5 (https=)
RU2016150486A (ru) Ингибиторы бета-лактамазы
JP2019531279A5 (https=)
JP2019501223A5 (https=)
JP2019501927A5 (https=)
JP2011511835A5 (https=)
JP2018510235A5 (https=)
JP2016520618A5 (https=)
JP2021500403A5 (https=)
JP2012504133A5 (https=)
JP2017501236A5 (https=)
JP2019516739A5 (https=)
JP2017504635A5 (https=)
JP2020502047A5 (https=)
JP2014097964A5 (https=)
JP2017506666A5 (https=)